Market Cap (In USD)
935.82 Thousand
Revenue (In USD)
-
Net Income (In USD)
-4.88 Million
Avg. Volume
23.19 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.0E-4-0.021
- PE
- -
- EPS
- -0.02
- Beta Value
- 0.66
- ISIN
- CA6936971044
- CUSIP
- -
- CIK
- 1833371
- Shares
- 9358210000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Evan Mike Levine
- Employee Count
- -
- Website
- https://www.psybiolife.com
- Ipo Date
- 2021-04-23
- Details
- PsyBio Therapeutics Corp., a biotechnology company, focuses on the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. The company is headquartered in Coconut Creek, Florida.
More Stocks
-
DVYSR
-
1798Moriya Corporation
1798
-
3630
-
2916
-
FCNCB
-
NCLINDNCL Industries Limited
NCLIND
-
ALTX
-
AVCRFAvricore Health Inc.
AVCRF